Department of Otolaryngology-Head and Neck Surgery, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ 07103, USA.
Int Forum Allergy Rhinol. 2013 Aug;3(8):670-7. doi: 10.1002/alr.21162. Epub 2013 Mar 20.
This study reviews the published literature related to management of sinonasal chondrosarcoma. Clinical presentation, demographics, radiographic diagnosis, treatment, and management outcomes of this uncommon disease are reported.
A systematic review of studies for sinonasal chondrosarcoma from 1950 to 2012 was conducted. A PubMed search for articles related to this condition, along with bibliographies of the selected articles was performed. Articles were examined for patient data that reported survivability. Demographic data, disease site, treatment strategies, follow-up, outcome, and survival were analyzed.
A total of 63 journal articles were included, comprising a total of 161 cases of sinonasal chondrosarcoma. The average follow-up was 77.4 months (range, 1 to 325.2 months). Surgical resection was the most common treatment modality, used in 72.0% of cases. A combination of surgery and radiation therapy was the second most commonly used treatment modality, used in 21.7% of cases.
This review contains the largest pool of sinonasal chondrosarcoma patients to date and suggests aggressive surgical resection is the most common treatment modality for this condition. The use of adjuvant radiotherapy for prevention of local recurrence after subtotal or total resection has not been proven effective. However, the use of radiotherapy in addition to surgical resection has shown benefit in some studies in terms of survival.
本研究回顾了与鼻窦软骨肉瘤的管理相关的已发表文献。报告了这种罕见疾病的临床表现、人口统计学、放射学诊断、治疗和管理结果。
对 1950 年至 2012 年的鼻窦软骨肉瘤研究进行了系统回顾。对与该疾病相关的文章进行了 PubMed 搜索,并对选定文章的参考文献进行了搜索。对报告生存率的患者数据进行了检查。分析了人口统计学数据、疾病部位、治疗策略、随访、结果和生存情况。
共纳入 63 篇期刊文章,共包括 161 例鼻窦软骨肉瘤患者。平均随访时间为 77.4 个月(范围为 1 至 325.2 个月)。手术切除是最常见的治疗方式,在 72.0%的病例中使用。手术和放疗联合是第二常见的治疗方式,在 21.7%的病例中使用。
本综述包含了迄今为止最大的鼻窦软骨肉瘤患者群体,表明积极的手术切除是该疾病最常见的治疗方式。辅助放疗用于预防次全或全切后局部复发尚未被证明有效。然而,在一些研究中,放疗联合手术切除在生存方面显示出益处。